Bachelor's degree in Clinical Medicine from Soochow University Medical College, and a Master's degree in Finance from Shanghai University of Finance and Economics. Previously worked at Novartis Pharmaceuticals, EPS Corporation, and the IBD of Citi Orient. Well-versed in the medical industry, with expertise in product R&D, registration, manufacturing, marketing, and sales in hospital terminals. Familiar with the medical environment, national industrial policies, and relevant laws, as well as regulations and medical environments in countries such as the United States, Japan, and the European Union. Proficient in financial regulations and investment banking products such as IPOs, M&As, restructuring, refinancing, various types of bonds, fixed income products, private equities, and innovative financial products, excelling in various capital operations, especially primary market investments.

Successful Cases: Starry (603520), Tigermed Consulting (300347), Valiant (002643), Biotecan Pharmaceuticals (835720), and Shimei Pharmaceutical (836706).